Glaxo gets hostile in bid for HGS

Pharmaceutical giant in $2.6bn takeover move on long-time treatments partner

GlaxoSmithKline turned hostile against its long-term partner Human Genome Sciences yesterday, revealing it has approached the US-based biotech with a $2.6bn (£1.6bn) offer that HGS rejected.

Britain's biggest drug maker approached HGS's board with a $13-a-share cash offer, more than more than 80 per cent higher than the US group's closing share price on Wednesday. But the board immediately rejected the unsolicited offer, claiming it "does not reflect the value" of the company and said it was considering putting itself up for sale.

Glaxo and HGS have worked together successfully on Benlysta, the first new drug approved for lupus in the US in half a century – although HGS's share price has been hit this year after initial sales of the drug disappointed.

Both companies are also co-developing two other experimental drugs: darapladib to treat heart disease and type-two diabetes drug albiglutide, which are both also in late-stage trials.

Glaxo's chief executive Sir Andrew Witty said: "Having worked together with Human Genome Sciences for nearly 20 years, we believe there is clear strategic and financial logic to this combination for both companies and our respective shareholders – and that now is the appropriate time... for our two companies to combine."

He said the offer eliminated "substantial execution risk" for HGS shareholders and delivered value superior to what "HGS can reasonably expect to create as a standalone company."

Glaxo said it would expect to achieve at least $200m in cost synergies from the deal by 2015 and anticipates it would boost earnings by 2013. The pharmaceuticals giant said the acquisition would not influence its buyback programme, and that it expects to repurchase £1bn to £2bn in shares this year.

Sir Andrew added: "We are disappointed that Human Genome Sciences has rejected our offer without discussion and are confident that our offer is in the best interest of shareholders of both companies."

Glaxo has hired Lazard and Morgan Stanley as financial advisers on the deal. It has also secured law firms Cleary Gottlieb Steen & Hamilton and Wachtell, Lipton, Rosen & Katz for legal advice. HGS has hired Goldman Sachs and Credit Suisse to protect itself from Glaxo's approach, plus US law firm Skadden, Arps, Slate, Meagher & Flom and City giant DLA Piper.

Sir Andrew wrote to Thomas Watkins, the chief executive of HGS last week, saying: "We believe the acquisition can be completed expeditiously and are prepared to commence a cash tender offer with no financing or due diligence condition. We are prepared to move forward immediately. We are confident that the transaction will promptly receive all necessary regulatory approvals, including antitrust clearances."

Drug makers are facing growing pains, with blockbuster medicines going off patent, and are turning to M&A as a solution. Between 2008 and 2010 the industry saw a string of mega-deals, including Pfizer acquiring Wyeth for $68bn, Novartis buying the rest of Alcon for $39bn, and Roche buying Genentech for $46.8bn. So far this year, pharmaceutical deals worth $18.5bn have been announced, 5 per cent above the same time a year ago, according to Dealogic.

PROMOTED VIDEO
Life and Style
techYahoo Japan launches service to delete your files and email your relatives when you die
Life and Style
Child's play: letting young people roam outdoors directly contradicts the current climate
lifeHow much independence should children have?
Arts and Entertainment
Tycoons' text: Warren Buffett and Bill Gates both cite John Brookes' 'Business Adventures' as their favourite book
booksFind out why America's richest men are reading John Brookes
News
i100
Arts and Entertainment
<p><strong>2008</strong></p>
<p>Troubled actor Robert Downey Jr cements his comeback from drug problems by bagging the lead role in Iron Man. Two further films follow</p>
filmRobert Downey Jr named Hollywood's highest paid actor for second year running
Life and Style
Dale Bolinger arranged to meet the girl via a fetish website
life
Property
Sign here, please: Magna Carta Island
propertyYours for a cool £4m
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Training Programme Manager (Learning and Development)-London

£28000 - £32000 per annum + benefits: Ashdown Group: Training Programme Manage...

Training/Learning and Development Coordinator -London

£28000 - £32000 per annum: Ashdown Group: Training/Learning and Development Co...

Business Anaylst

£60000 - £75000 per annum + BONUS + BENEFITS: Harrington Starr: Business Anal...

Project Manager - ETRM/CTRM

£70000 - £90000 per annum + Job Satisfaction: Harrington Starr: Project Manage...

Day In a Page

Some are reformed drug addicts. Some are single mums. All are on benefits. But now these so-called 'scroungers’ are fighting back

The 'scroungers’ fight back

The welfare claimants battling to alter stereotypes
Amazing video shows Nasa 'flame extinguishment experiment' in action

Fireballs in space

Amazing video shows Nasa's 'flame extinguishment experiment' in action
A Bible for billionaires

A Bible for billionaires

Find out why America's richest men are reading John Brookes
Paranoid parenting is on the rise - and our children are suffering because of it

Paranoid parenting is on the rise

And our children are suffering because of it
For sale: Island where the Magna Carta was sealed

Magna Carta Island goes on sale

Yours for a cool £4m
Phone hacking scandal special report: The slide into crime at the 'News of the World'

The hacker's tale: the slide into crime at the 'News of the World'

Glenn Mulcaire was jailed for six months for intercepting phone messages. James Hanning tells his story in a new book. This is an extract
We flinch, but there are degrees of paedophilia

We flinch, but there are degrees of paedophilia

Child abusers are not all the same, yet the idea of treating them differently in relation to the severity of their crimes has somehow become controversial
The truth about conspiracy theories is that some require considering

The truth about conspiracy theories is that some require considering

For instance, did Isis kill the Israeli teenagers to trigger a war, asks Patrick Cockburn
Alistair Carmichael: 'The UK as a whole is greater than the sum of its parts'

Alistair Carmichael: 'The UK as a whole is greater than the sum of its parts'

Meet the man who doesn't want to go down in history as the country's last Scottish Secretary
Legoland Windsor's master model-makers reveal the tricks of their trade (including how to stop the kids wrecking your Eiffel Tower)

Meet the people who play with Lego for a living

They are the master builders: Lego's crack team of model-makers, who have just glued down the last of 650,000 bricks as they recreate Paris in Windsor. Susie Mesure goes behind the scenes
The 20 best days out for the summer holidays: From Spitfires to summer ferry sailings

20 best days out for the summer holidays

From summer ferry sailings in Tyne and Wear and adventure days at Bear Grylls Survival Academy to Spitfires at the Imperial War Museum Duxford and bog-snorkelling at the World Alternative Games...
Open-air theatres: If all the world is a stage, then everyone gets in on the act

All the wood’s a stage

Open-air productions are the cue for better box-office receipts, new audiences, more interesting artistic challenges – and a picnic
Rand Paul is a Republican with an eye on the world

Rupert Cornwell: A Republican with an eye on the world

Rand Paul is laying out his presidential stall by taking on his party's disastrous record on foreign policy
Self-preservation society: Pickles are moving from the side of your plate to become the star dish

Self-preservation society

Pickles are moving from the side of your plate to become the star dish
Generation gap opens a career sinkhole

Britons live ever longer, but still society persists in glorifying youth

We are living longer but considered 'past it' younger, the reshuffle suggests. There may be trouble ahead, says DJ Taylor